You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastasized

Showing 26 - 50 of 232
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Carcinoma, Metastatic Cancer Trial in Austria (Next Generation Sequencing, Biomarker Monitoring)

Recruiting
  • Locally Advanced Carcinoma
  • Metastatic Cancer
  • Next Generation Sequencing
  • Biomarker Monitoring
  • Innsbruck, Tirol, Austria
  • +4 more
Mar 10, 2022

Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

Completed
Has Results
  • Stage II Prostate Adenocarcinoma
  • Stage III Prostate Adenocarcinoma
  • Palo Alto, California
    Stanford University, School of Medicine
Mar 2, 2022

Lung Cancer Trial in Seoul (99mTc-MSA-ICG)

Recruiting
  • Lung Cancer
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Sep 9, 2021

Solid Tumor Trial (BS006 Injection)

Not yet recruiting
  • Solid Tumor
  • BS006 Injection
  • (no location specified)
Jul 3, 2023

Breast Cancer, Radiation Toxicity Trial in Ghent (Radiotherapy)

Completed
  • Breast Cancer
  • Radiation Toxicity
  • Radiotherapy
  • Ghent, Oost-Vlaanderen, Belgium
  • +1 more
Jan 3, 2023

Solid Tumor Trial (OH2 Injection)

Not yet recruiting
  • Solid Tumor
  • OH2 Injection
  • (no location specified)
Jul 12, 2023

Clinical Relevance of PSMA Expression in Malignant Gastrointestinal Tumors Trial in Wuerzburg (18F-PSMA PET/CT)

Recruiting
  • Clinical Relevance of PSMA Expression in Malignant Gastrointestinal Neoplasms
  • 18F-PSMA PET/CT
  • Wuerzburg, Bavaria, Germany
    University Hospital Wuerzburg
Sep 15, 2022

Gastrointestinal Cancer Metastatic Trial (MRI/Spectroscopy)

Recruiting
  • Gastrointestinal Cancer Metastatic
  • MRI/Spectroscopy
  • Pisa, Italy
  • +3 more
Dec 15, 2022

NSCLC Trial in Nijmegen (Pembrolizumab)

Recruiting
  • NSCLC
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Jul 11, 2021

The HELPP Score: A Pretreatment Score to Predict Survival in

Not yet recruiting
  • Pancreatic Adenocarcinoma
    • Vienna, Austria
      Department of General Surgery, Division of Visceral Surgery, Med
    Feb 21, 2023

    Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8 Trial in Atlanta

    Recruiting
    • Stage II Gallbladder Cancer AJCC v8
    • +5 more
    • Atlanta, Georgia
      Emory University, Winship Cancer Institute
    Jan 3, 2023

    Breast Cancer Trial in Shenyang (SLNB, pALND, ALND)

    Recruiting
    • Breast Cancer
    • SLNB
    • +2 more
    • Shenyang, Liaoning, China
    • +1 more
    Feb 6, 2022

    Gut Microbiome in Anti-tumor Therapy Induced Diarrhea

    Recruiting
    • Cancer
      • Graz, Austria
        Department of Internal Medicine, Medical University of Graz
      May 15, 2023

      Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like

      Recruiting
      • Pancreatic Cancer
      • Metastatic Pancreatic Cancer
      • Irreversible Electroporation (IRE)
      • +2 more
      • Amsterdam, North-Holland, Netherlands
        Amsterdam University Medical Centre (location VUmc)
      Dec 18, 2022

      Shear-wave Elastography in Breast Cancer

      Not yet recruiting
      • Breast Cancer
      • elastography
      • (no location specified)
      Nov 3, 2023

      Pancreatic Cancer Non-resectable Trial in Amsterdam, Utrecht (stereotactic ablative radiotherapy)

      Recruiting
      • Pancreatic Cancer Non-resectable
      • stereotactic ablative radiotherapy
      • Amsterdam, Noord-Holland, Netherlands
      • +1 more
      Feb 22, 2022

      Pancreatic Cancer Trial (Rintatolimod)

      Not yet recruiting
      • Pancreatic Cancer
      • (no location specified)
      Aug 8, 2022

      Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)

      Not yet recruiting
      • Prostate Cancer
      • [177Lu]Lu-PSMA I&T
      • Stereotactic Radiotherapy
      • (no location specified)
      May 30, 2023

      Colorectal Cancer Trial (Administration of CC-3)

      Not yet recruiting
      • Colorectal Cancer
      • Administration of CC-3
      • (no location specified)
      Aug 11, 2023

      Lung Cancer, Extensive-stage Small-cell Lung Cancer, Radiotherapy Trial (Durvalumab + carboplatin/cisplatin + etoposide,

      Not yet recruiting
      • Lung Cancer
      • +2 more
      • Durvalumab + carboplatin/cisplatin + etoposide
      • +2 more
      • (no location specified)
      Aug 3, 2022

      Brain Metastases, Adult Trial in Pittsburgh (Pre-operative Stereotactic Radiosurgery)

      Recruiting
      • Brain Metastases, Adult
      • Pre-operative Stereotactic Radiosurgery
      • Pittsburgh, Pennsylvania
        Allegheny General Hospital
      Apr 18, 2022

      NSCLC Stage I Trial in Shanghai (traditional Chinese medicine and ablation in the primary tumor sites, ablation)

      Recruiting
      • Non-small Cell Lung Cancer Stage I
      • traditional Chinese medicine and ablation in the primary tumor sites
      • ablation
      • Shanghai, Shanghai, China
        Shanghai 10th People's Hospital
      Oct 27, 2021

      Benchmarking of Top Performing ctDNA Diagnostics - Colorectal

      Recruiting
      • Colorectal Cancer Stage III
      • Liver Metastasis Colon Cancer
        • Graz, Steiermark, Austria
        • +14 more
        Nov 1, 2023

        Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

        Active, not recruiting
        • Metastatic Malignant Neoplasm in Lymph Node
        • +3 more
        • Antiandrogen Therapy
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Mar 3, 2022

        Antiangiogenic Therapy in Metastasized Renal Cell Carcinoma

        Completed
        • Metastatic Renal Cancer
        • Perfusion-CT
        • München, Bavaria, Germany
          Urologische Klinik und Poliklinik der Universität München
        Sep 28, 2018